Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Amyloid Fibrils03:03

Amyloid Fibrils

12.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating Alzheimer's Disease-Associated Genes Using Differential Splicing Frequency Analysis.

Cells·2026
Same author

Genomic Basis of Zoonotic Transmission and Antifungal Resistance in <i>Microsporum canis</i>.

Journal of fungi (Basel, Switzerland)·2026
Same author

Enhanced nitrogen and phosphorus co-removal mediated by quorum sensing in novel cold-resistant strain LD-01: Mechanisms and application in hyporheic zones during freeze-thaw cycles.

Bioresource technology·2026
Same author

Toward Optimized Platinum Therapy: A Risk Prediction Model for Toxicity Based on Platinum Accumulation and Its Impact on Treatment Outcomes.

Drug design, development and therapy·2026
Same author

TIPE3 in Cancer: A Multifaceted Regulator of Tumorigenesis, Therapeutic Resistance, and Clinical Outcomes.

Technology in cancer research & treatment·2026
Same author

Bioinspired silk-catechol-enzyme co-assemblies as jigsaw-designed conformation-locking bioactive-biocatalytic platforms.

Bioactive materials·2026
Same journal

Postoperative Impairment of GluA2 Ttrafficking in CA3 Induces Memory Consolidation Deficits in Aged Mice by Disrupting SPW-R in CA1.

Journal of molecular neuroscience : MN·2026
Same journal

MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy.

Journal of molecular neuroscience : MN·2026
Same journal

Notch Signaling Regulates the Neuroprotective Effects of hUCMSCs in a Mouse Model of Cerebral Ischemia.

Journal of molecular neuroscience : MN·2026
Same journal

Co-Administration of LPC and LPS Enhanced the Spinal Cord Vulnerability in a Mouse Model of Focal Demyelination.

Journal of molecular neuroscience : MN·2026
Same journal

Biomarker Based ARIA Stress Test: A Proposed Conceptual Framework for Dynamic Biomarker-Guided ARIA Risk Stratification in Anti-Amyloid Immunotherapy for Alzheimer's Disease.

Journal of molecular neuroscience : MN·2026
Same journal

The Association Between Alzheimer's Disease-Related Biomarkers And Parkinson's Disease Based On Single-Cell Sequencing Analysis Combined With Mendelian Randomization.

Journal of molecular neuroscience : MN·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

37.5K

A Preliminary Study: PS1 Increases U1 snRNA Expression Associated with AD.

Zhi Cheng1, Zhanqiang Du2, Yingchun Shang1

  • 1College of Life Sciences and Key Laboratory of Bioactive Materials Ministry of Education, Nankai University, 300071, Tianjin, People's Republic of China.

Journal of Molecular Neuroscience : MN
|June 4, 2017
PubMed
Summary
This summary is machine-generated.

Presenilin1 (PS1) mutations elevate U1 small nuclear RNA (snRNA) levels, driving Alzheimer's disease (AD) pathology, including amyloid-beta production, tau hyperphosphorylation, and cell apoptosis.

Keywords:
AβPS1SH-SY5Y cellsThr212U1 snRNA

More Related Videos

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain
09:35

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain

Published on: October 24, 2017

13.0K
Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

632

Related Experiment Videos

Last Updated: Mar 1, 2026

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

37.5K
Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain
09:35

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain

Published on: October 24, 2017

13.0K
Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

632

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Familial Alzheimer's disease (AD) is linked to mutations in presenilin1 (PS1) and amyloid precursor protein (APP).
  • U1 small nuclear RNA (snRNA) is consistently found at high levels in familial AD cases.
  • The specific cause of U1 snRNA overexpression in AD pathogenesis remains unclear.

Purpose of the Study:

  • To investigate the role of PS1 in U1 snRNA overexpression.
  • To determine the downstream effects of U1 snRNA on AD-related molecular pathways.
  • To explore the potential of U1 snRNA as a therapeutic target in AD.

Main Methods:

  • Utilized SH-SY5Y neuroblastoma cells for experimental models.
  • Quantified U1 snRNA levels and Aβ production.
  • Analyzed apoe and clu transcript levels.
  • Assessed tau protein phosphorylation at Thr212 via immunofluorescence.
  • Evaluated apoptosis markers (Bax, Bcl2) and Bax/Bcl2 ratio.

Main Results:

  • PS1 was found to induce U1 snRNA overexpression in vitro.
  • U1 snRNA overexpression led to increased amyloid-beta (Aβ) production.
  • Elevated apoe and clu transcripts were observed with U1 snRNA overexpression.
  • Significant tau protein phosphorylation at Thr212 and cytoskeletal association was noted.
  • Increased Bax, Bcl2, and Bax/Bcl2 ratio indicated U1 snRNA-induced cell apoptosis.

Conclusions:

  • PS1 significantly upregulates U1 snRNA levels.
  • U1 snRNA overexpression contributes to key Alzheimer's disease pathologies.
  • Findings link U1 snRNA to Aβ levels, tau pathology, and apoptosis in AD.